Prediction of Malignant Transformation in Oral Epithelial Dysplasia Using Infrared Absorbance Spectra
Overview
Authors
Affiliations
Oral epithelial dysplasia (OED) is a histopathologically-defined, potentially premalignant condition of the oral cavity. The rate of transformation to frank carcinoma is relatively low (12% within 2 years) and prediction based on histopathological grade is unreliable, leading to both over- and under-treatment. Alternative approaches include infrared (IR) spectroscopy, which is able to classify cancerous and non-cancerous tissue in a number of cancers, including oral. The aim of this study was to explore the capability of FTIR (Fourier-transform IR) microscopy and machine learning as a means of predicting malignant transformation of OED. Supervised, retrospective analysis of longitudinally-collected OED biopsy samples from 17 patients with high risk OED lesions: 10 lesions transformed and 7 did not over a follow-up period of more than 3 years. FTIR spectra were collected from routine, unstained histopathological sections and machine learning used to predict malignant transformation, irrespective of OED classification. PCA-LDA (principal component analysis followed by linear discriminant analysis) provided evidence that the subsequent transforming status of these 17 lesions could be predicted from FTIR data with a sensitivity of 79 ± 5% and a specificity of 76 ± 5%. Six key wavenumbers were identified as most important in this classification. Although this pilot study used a small cohort, the strict inclusion criteria and classification based on known outcome, rather than OED grade, make this a novel study in the field of FTIR in oral cancer and support the clinical potential of this technology in the surveillance of OED.
Alajaji S, Sabzian R, Wang Y, Sultan A, Wang R Cancers (Basel). 2025; 17(5).
PMID: 40075644 PMC: 11899414. DOI: 10.3390/cancers17050796.
Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance.
Ingham J, Ruan J, Coelho M BJC Rep. 2025; 3(1):11.
PMID: 40016372 PMC: 11868516. DOI: 10.1038/s44276-025-00129-2.
Al Jedani S, Lima C, Smith C, Gunning P, Shaw R, Barrett S Sci Rep. 2024; 14(1):16050.
PMID: 38992088 PMC: 11239877. DOI: 10.1038/s41598-024-66977-z.
Alajaji S, Khoury Z, Jessri M, Sciubba J, Sultan A Head Neck Pathol. 2024; 18(1):38.
PMID: 38727841 PMC: 11087425. DOI: 10.1007/s12105-024-01643-4.
Confer M, Falahkheirkhah K, Surendran S, Sunny S, Yeh K, Liu Y J Pers Med. 2024; 14(3).
PMID: 38541046 PMC: 10971207. DOI: 10.3390/jpm14030304.